Computational Systems Biology Sheds Insights on to Metabolic Syndrome and its Component Disorders
DOI: https://doi.org/10.33263/briac113.99049914
2020-09-23
Biointerface Research in Applied Chemistry
Abstract:The interconnected physiological and metabolism factors, such as obesity, hypertension, insulin resistance, etc. that increases the risk of cardiovascular disorders (CVD), type2 diabetes mellitus (T2DM) that causes mortality is the description of metabolic syndrome (MetS). It remains unclear how molecular mechanisms are typical between MetS, CVD, T2DM, obesity, and hypertension. In this study, we compiled 27 common genes by mapping miRNAs and TFs as active seed nodes into the regulatory TF-miRNAs and TF-miRNA networks by the integration of target prediction. By merging these networks, the gene-based miRNA and TF mediated regulatory network common for MetS and its associated diseases were constructed. As a result, we obtained a potential active sub-network based on degree analysis. Next, by using the breadth-first-search approach, 46 regulatory pathways, which are the gene-based regulatory cascade of TFs and miRNAs, were identified. In order to identify the hub regulators in the original network constructed, based on degree and betweenness analysis, 16 genes (VEGFA, KLF2, PNPLA3, GRK2, HMOX1, EDN1, IL6, TGFB1, NOS3, TNF, SERPINA1, SPP1, AGTR1, ADRB3), 3 miRNAs(has-miR-335-5p, has-miR-124-3p, has-miR-181a-5p), 4TFs(NFKB, FOXO1, RELA, SP1) are over-represented in the following significantly enriched functional pathway groups such as AGE-RAGE signaling pathway, Renin-Angiotensin System, HIF-1 signaling pathway. The majority of the regulatory relationships from published literature studies demonstrated the reliability and validity of these miRNA and TF mediated regulatory network. Hence, our study has aided in deciphering the complex regulatory mechanisms involved in MetS and will provide putative therapeutic targets by further validation of these pathways by biological experiments.